Relationship between immunosuppression and intensive care unit-acquired multidrug-resistant bacteria: A case-control study*
Authors:
- Saad NseirSNSaad Nseir
- Christophe Di PompeoCPChristophe Di Pompeo
- Maimouna DiarraMDMaimouna Diarra
- Hélène BrissonHBHélène Brisson
- Stéphanie TissierSTStéphanie Tissier
- Marie BouloMBMarie Boulo
- Alain DurocherADAlain Durocher
- 1 May 2007
- journal article
- conference paper
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 35 (5) , 1318-1323
Abstract
To determine the relationship between immunosuppression and intensive care unit (ICU)-acquired multidrug-resistant (MDR) bacteria. Retrospective case-control study based on prospectively collected data. A 30-bed medical and surgical ICU. All patients hospitalized >48 hrs in the ICU were eligible during a 2-yr period. Immunosuppression was defined as active solid or hematologic malignancy, leucopenia, or chronic immunosuppressive treatment. MDR bacteria were defined as methicillin-resistant Staphylococcus aureus, ceftazidime- or imipenem-resistant Pseudomonas aeruginosa, Acinetobacter baumannii, Stenotrophomonas maltophilia, and extending spectrum β-lactamase producing Gram-negative bacilli. MDR bacteria screening (nasal, anal, and axilla swabs and tracheal aspirate in intubated patients) was performed at ICU admission and weekly. Only MDR bacteria isolated >48 hrs after ICU admission were taken into account; duplicates were excluded. Isolation measures were applied in all patients at ICU admission, in patients with MDR bacteria, and in patients with immunosuppression. Immunosuppressed patients (cases) were matched (1:1) with immunocompetent patients (controls) according to all the following criteria: age ±5 yrs, Simplified Acute Physiology Score II ±5, duration of ICU stay ±3 days, and category of admission (medical/surgical). Risk factors for ICU-acquired MDR bacteria were determined using univariate and multivariate analyses. Of 1,065 eligible patients, nine patients were excluded for absence of MDR bacteria screening at ICU admission. One hundred thirty-three (12%) patients were immunosuppressed, and 128 (96%) of them were successfully matched. Mean time between ICU admission and first ICU-acquired MDR bacteria was 12 ± 9 days. Incidence of MDR bacteria was significantly higher in cases than in controls (22 vs. 12 MDR bacteria/1000 ICU days, p = .004). However, immunosuppression was not independently associated with ICU-acquired MDR bacteria. Multivariate analysis identified prior antibiotic treatment and antibiotic treatment in the ICU as risk factors for ICU-acquired MDR bacteria (odds ratio [95% confidence interval] = 1.9 [1–3.6], p = .003; 11 [1.4–83], p = .02; respectively). Immunosuppression is not independently associated with ICU-acquired MDR bacteria. However, infection control measures used in our ICU may have influenced this result.Keywords
This publication has 36 references indexed in Scilit:
- Cost of Gram-negative resistance*Critical Care Medicine, 2007
- Cross-transmission of nosocomial pathogens in an adult intensive care unit: incidence and risk factorsJournal of Hospital Infection, 2006
- Frequency, characteristics, and predictors of microbiologically documented nosocomial infections after cardiac surgeryEuropean Journal of Cardio-Thoracic Surgery, 2006
- Nosocomial Pneumonia, Including Ventilator-associatedPneumoniaProceedings of the American Thoracic Society, 2005
- Streptococcus pneumoniae Bacteremia in Patients With CancerMedicine, 2005
- SAPS 3—From evaluation of the patient to evaluation of the intensive care unit. Part 1: Objectives, methods and cohort descriptionIntensive Care Medicine, 2005
- Carriage of methicillin-resistant Staphylococcus aureus, ceftazidime-resistant Gram-negative bacilli, and vancomycin-resistant enterococci before and after intensive care unit admissionCritical Care Medicine, 2003
- Appropriate use of antimicrobial agents: Challenges and strategies for improvementCritical Care Medicine, 2003
- Reduction of Nosocomial Infection during Pediatric Intensive Care by Protective IsolationNew England Journal of Medicine, 1989
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988